Precept Bio develops compact bioreactor systems that allow hospitals to manufacture patient-derived cell therapies on-site, eliminating shipping delays and centralised manufacturing bottlenecks. The technology is being validated through clinical pilots at major Australian research hospitals in partnership with CSIRO's Biotech team. Early data shows production time reduction of 40% compared to traditional centralized facilities.